[Muscle pain and statin, pharmacological or nocebo effect?]

Charles Khouri; Marion Lepelley; Michel Mallaret; Matthieu Roustit; Jean-Luc Cracowski

doi:10.1016/j.therap.2017.12.004

[Muscle pain and statin, pharmacological or nocebo effect?]

Therapie. 2018 Sep;73(4):359-361. doi: 10.1016/j.therap.2017.12.004. Epub 2017 Dec 24.

[Article in French]

Authors

Charles Khouri¹, Marion Lepelley², Michel Mallaret², Matthieu Roustit³, Jean-Luc Cracowski³

Affiliations

¹ Centre régional de pharmacovigilance, CHU Grenoble-Alpes, 38043 Grenoble, France; Unité de pharmacologie clinique, centre d'investigation clinique, inserm CIC1406, CHU Grenoble-Alpes, 38043 Grenoble, France; Laboratoire HP2, inserm UMR 1042, université Grenoble Alpes, 38700 La Tronche, France. Electronic address: CKhouri@chu-grenoble.fr.
² Centre régional de pharmacovigilance, CHU Grenoble-Alpes, 38043 Grenoble, France.
³ Unité de pharmacologie clinique, centre d'investigation clinique, inserm CIC1406, CHU Grenoble-Alpes, 38043 Grenoble, France; Laboratoire HP2, inserm UMR 1042, université Grenoble Alpes, 38700 La Tronche, France.

PMID: 29366501
DOI: 10.1016/j.therap.2017.12.004

No abstract available

Keywords: Effet nocebo; Inhibiteur de hydroxy-méthyl-glutaryl -coa reductase; Myalgia; Myalgie; Nocebo effect; hydroxy-methyl-glutaryl -coa reductase inhibitors.

Publication types

Letter

MeSH terms

Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
Myalgia / chemically induced*
Nocebo Effect*

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors